ABSTRACT India, with the second-largest population globally after China, and one of the worst-hit countries by the COVID-19 pandemic, is facing significant challenges due to its poorly managed biomedical waste system. The lack of public awareness and resources is exacerbating the problem, putting hospital personnel, physicians, nurses, patients, and visitors at risk of exposure to biomedical waste. Proper training for those handling and managing biomedical waste is critical in preventing further virus transmission. Inadequate treatment and management of BMW can result in contamination of soil, air, and water, which can lead to the transmission of diseases and various health issues. India has seen a 25% increase in daily biomedical waste generation in 2020 as a result of COVID-19. As a result, new guidelines and strategies are being implemented by various countries to safely manage the increased amounts of biomedical waste, including COVID-19 waste. A step towards regulating and controlling BMW activities in the nation was taken with the implementation of the BMW management rules 2016 and the amendment Rules 2019. To stop the COVID-19 pandemic from spreading and to safeguard the security of medical staff, patients, and the general public, efficient biomedical waste management is essential. Keywords: Biomedical waste, COVID-19 Waste, CPCB (The Central Pollution Control Board), SPCBs (State Pollution Control Boards), PCCs (Pollution Control Committees), ULBs (Urban Local Bodies), CBWTF (Common Bio-medical Waste Treatment Facility), HCFs (Health Care Facilities), BMWM (Bio-medical Waste Management).